Skip to content

Mark Walter Frohlich

NPI 1366528168ActiveIndividual· Internal Medicine, Medical Oncology· Seattle, WA

Internal Medicine, Medical Oncology in Seattle, Washington, licensed in WA, with an NPI issued in October 2006. Rigel Pharmaceuticals, Inc. was the largest of 2 companies reporting payments in 2025, $41,337 in all, mostly consulting fees.

Overview

NPI1366528168
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedOct 27, 2006
Last updated in NPPESDec 28, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Medical Oncology Primary207RX0202XMD00040829WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$41,337 · 6 payments from 2 companies
  • 2024$20.70 · 1 payment from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$41,310 · 5 payments
  • Food and Beverage$26.83 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other medical oncologists in Seattle

All 94 medical oncologists in Seattle · All medical oncologists in Washington